| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |